Predicting the effects of parasite co-infection across species boundaries.

It is normal for hosts to be co-infected by parasites. Interactions among co-infecting species can have profound consequences, including changing parasite transmission dynamics, altering disease severity and confounding attempts at parasite control. Despite the importance of co-infection, there is currently no way to predict how different parasite species may interact with one another, nor the consequences of those interactions. Here, we demonstrate a method that enables such prediction by identifying two nematode parasite groups based on taxonomy and characteristics of the parasitological niche. From an understanding of the interactions between the two defined groups in one host system (wild rabbits), we predict how two different nematode species, from the same defined groups, will interact in co-infections in a different host system (sheep), and then we test this experimentally. We show that, as predicted, in co-infections, the blood-feeding nematode Haemonchus contortus suppresses aspects of the sheep immune response, thereby facilitating the establishment and/or survival of the nematode Trichostrongylus colubriformis; and that the T. colubriformis-induced immune response negatively affects H. contortus This work is, to our knowledge, the first to use empirical data from one host system to successfully predict the specific outcome of a different co-infection in a second host species. The study therefore takes the first step in defining a practical framework for predicting interspecific parasite interactions in other animal systems.

Dietary modulation of the mucosal immune response to a parasite.

This study investigated the hypothesis that dietary deficiency of readily available carbohydrate (raCHO) modifies the immune response of lambs to the gastrointestinal nematode Trichostrongylus colubriformis. Sixty helminthologically naive Merino lambs were fed throughout the experiment diets containing three levels of raCHO that provided adequate, moderate or low intakes according to recommended standards and were given primary or both primary and secondary infections of T. colubriformis. A further 20 uninfected lambs received the low diet for 9 weeks, after which they were returned to the standard diet. Immune status was assessed by the measurement of plasma and jejunal antibody concentrations and blood and jejunal cell numbers and function. Diets low in carbohydrate resulted in a failure of the lambs to gain weight and decreases in plasma glucose concentration, blood lymphocytes expressing CD8 or Tcrgammadelta, monocytes, eosinophils, platelets and red blood cells, jejunal and plasma antibody concentrations, lymphocyte proliferation to worm antigen and numbers of jejunal CD8(+) and Tcrdeltagamma(+) lymphocytes, eosinophils and CD1b(+) dendritic cells. Thus, a low dietary concentration of raCHOs impaired the constitutive availability of lymphocytes and antigen-presenting cells, and the cellular and humoral immunological responses. A hypothesis is suggested for the mechanism and for the possible wider implications.

Potential applications of chitosan in veterinary medicine.

Chitosan is a partially deacetylated polymer obtained from the alkaline deacetylation of chitin which is a glucose-based unbranched polysaccharide widely distributed in nature as the principal component of exoskeletons of crustaceans and insects as well as of cell walls of some bacteria and fungi. Chitosan exhibits a variety of physicochemical and biological properties resulting in numerous applications in fields such as waste and water treatment, agriculture, fabric and textiles, cosmetics, nutritional enhancement, and food processing. In addition to its lack of toxicity and allergenicity, and its biocompatibility, biodegradability and bioactivity make it a very attractive substance for diverse applications as a biomaterial in pharmaceutical and medical fields, where it has been used for systemic and local delivery of drugs and vaccines. It also has bioactive properties in its own right. This paper reviews current veterinary applications for chitosan including wound healing, bone regeneration, analgesic and antimicrobial effects. It also discusses the potential application of chitosan to drug and vaccine delivery in veterinary species. Given the restrictions imposed by financial and animal restraint considerations, especially in farming applications, the veterinary drug delivery areas most likely to benefit from chitosan are the delivery of chemotherapeutics such as antibiotics, antiparasitics, anaesthetics, painkillers and growth promotants to mucosal epithelium for absorption for local or systemic activity, and the delivery of immunomodulatory agents to the mucosal associated lymphoid tissue for induction or modulation of local immune responses. The properties of chitosan expected to enhance these functions are discussed, and the future research directions in this field are indicated.